This is an excellent literature review on the adjuvant use of rFVIIa in treating severe bleeding associated with surgical procedures in non-hemophiliac patients. It gives an overview of the mechanism of action of rFVIIa and its efficacy in patients with hemophilia, platelet dysfunction and liver disease. It also reviews its efficacy in managing bleeding in relation to svere trauma, cardiac surgery, intra-abdominal bleeding and prostatectomy. The review concludes that prospective randomized trials are required to study the efficacy of this novel hemostatic agent.
– Maadh Aldouri
NATA: Network for the advancement of Patient Blood Manegement, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Follow us
Subscribe to our newsletter
- Tutorials
- Resources
- Guides
- Examples
- Docs